RU96124055A - METHOD FOR TREATING EPILEPSY IN CHILDREN - Google Patents

METHOD FOR TREATING EPILEPSY IN CHILDREN

Info

Publication number
RU96124055A
RU96124055A RU96124055/14A RU96124055A RU96124055A RU 96124055 A RU96124055 A RU 96124055A RU 96124055/14 A RU96124055/14 A RU 96124055/14A RU 96124055 A RU96124055 A RU 96124055A RU 96124055 A RU96124055 A RU 96124055A
Authority
RU
Russia
Prior art keywords
children
treating epilepsy
treatment
epilepsy
blood
Prior art date
Application number
RU96124055/14A
Other languages
Russian (ru)
Other versions
RU2153891C2 (en
Inventor
Л.В. Смирнова
В.А. Васнякин
С.В. Власов
А.И. Мартынов
В.М. Крейнес
Original Assignee
Государственный научно-клинический центр охраны здоровья шахтеров
Новокузнецкий институт усовершенствования врачей
Filing date
Publication date
Application filed by Государственный научно-клинический центр охраны здоровья шахтеров, Новокузнецкий институт усовершенствования врачей filed Critical Государственный научно-клинический центр охраны здоровья шахтеров
Priority to RU96124055A priority Critical patent/RU2153891C2/en
Priority claimed from RU96124055A external-priority patent/RU2153891C2/en
Publication of RU96124055A publication Critical patent/RU96124055A/en
Application granted granted Critical
Publication of RU2153891C2 publication Critical patent/RU2153891C2/en

Links

Claims (1)

Способ лечения эпилепсии у детей, заключающийся в проведении медикаментозного лечения и плазмафереза, отличающийся тем, что после проведения центрифугирования забранной у ребенка крови в полученную клеточную массу вносят АТФ в дозе 100 мг/мл и реланиум 5-10 мг, инкубируют полученную смесь при 37oC в течение 20 мин и затем внутривенно капельно вводят ее пациенту, при этом курс лечения составляет 3 сеанса с интервалом между ними 2 суток.A method for the treatment of epilepsy in children, consisting in drug treatment and plasmapheresis, characterized in that after centrifugation of the blood collected from the child’s blood, ATP at a dose of 100 mg / ml and Relanium 5-10 mg are introduced into the resulting cell mass, the mixture is incubated at 37 o C for 20 minutes and then intravenously drip it to the patient, while the course of treatment is 3 sessions with an interval of 2 days between them.
RU96124055A 1996-12-24 1996-12-24 Method of treating epilepsy in children RU2153891C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96124055A RU2153891C2 (en) 1996-12-24 1996-12-24 Method of treating epilepsy in children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96124055A RU2153891C2 (en) 1996-12-24 1996-12-24 Method of treating epilepsy in children

Publications (2)

Publication Number Publication Date
RU96124055A true RU96124055A (en) 1999-02-27
RU2153891C2 RU2153891C2 (en) 2000-08-10

Family

ID=20188386

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96124055A RU2153891C2 (en) 1996-12-24 1996-12-24 Method of treating epilepsy in children

Country Status (1)

Country Link
RU (1) RU2153891C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2473333C2 (en) * 2011-03-24 2013-01-27 Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт педиатрии и детской хирургии" Министерства здравоохранения и социального развития Российской Федерации Method of suppressing epileptiforma activity and relief of epeleptic attacks in case of epileptic syndromes in children with electric epileptic status in phase of slow wave sleep

Similar Documents

Publication Publication Date Title
Gray et al. Effect of minor tranquillisers on hippocampal θ rhythm mimicked by depletion of forebrain noradrenaline
ES2137948T3 (en) ADVANCED SYSTEM OF ADMINISTRATION OF MEDICINES AND METHOD OF TREATMENT OF PSYCHIATRIC, NEUROLOGICAL AND OTHER DISORDERS WITH CARBAMACEPINE.
Splinter et al. Phase I study of alpha-difluoromethylornithine and methyl-GAG
RU96124055A (en) METHOD FOR TREATING EPILEPSY IN CHILDREN
CA2161970A1 (en) Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
Marolda et al. Clinical evaluation of (—) eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia
Alexopoulos et al. Unilateral electroconvulsive therapy: an open clinical comparison of two electrode placements.
SU1169655A1 (en) Method of treatment of thrombolytic diseases of the artery of the extremities
RU2078595C1 (en) Method for treatment of hepatic insufficiency
RU2070058C1 (en) Method of chronic bronchitis treatment
SU1034741A1 (en) Tuberculosis treatment method
RU96117561A (en) METHOD OF TREATING TOXICOMANIA
Olive Meaning in drug treatment.
SU1132946A1 (en) Method of treatment of immune insufficiency
宋宝珠 et al. SHORT-TERM EFFECT IN 135 CASES OF ENURESIS TREATED BY WRIST-ANKLE NEEDLING
Reinke et al. High incidence of haloperidol decanoate injection site reactions.
Ferguson et al. Diagnosis and treatment of pemphigus.
Tham et al. Serum amylase in patients treated with lithium.
SU1715355A1 (en) Method for hemosorption
SU874060A1 (en) Method of treating alcoholism
RU97108766A (en) METHOD FOR TREATING TOXIC-SEPTIC CONDITIONS IN NEWBORN CHILDREN
RU97113340A (en) METHOD FOR TREATING POSTOPERATIVE COCHLEAR DISORDERS
RU98110897A (en) METHOD FOR IMMUNOTHERAPY OF CHRONIC INFLAMMATORY DISEASES
Juorio Clinical evaluation of suloctidil vs. cinnarizine in both cerebrovascular and peripheral insufficiency.
Johnson The effects of lithium on the cerebellum.